Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Circulating tumor cells with stemness and epithelial-to-mesenchymal transition features are chemoresistant and predictive of poor outcome in metastatic breast cancer.

Papadaki MA, Stoupis G, Theodoropoulos PA, Mavroudis D, Georgoulias V, Agelaki S.

Mol Cancer Ther. 2018 Nov 6. pii: molcanther.0584.2018. doi: 10.1158/1535-7163.MCT-18-0584. [Epub ahead of print]

PMID:
30401696
2.

A Comparison of Three Methods for the Detection of Circulating Tumor Cells in Patients with Early and Metastatic Breast Cancer.

Politaki E, Agelaki S, Apostolaki S, Hatzidaki D, Strati A, Koinis F, Perraki M, Saloustrou G, Stoupis G, Kallergi G, Spiliotaki M, Skaltsi T, Lianidou E, Georgoulias V, Mavroudis D.

Cell Physiol Biochem. 2017;44(2):594-606. doi: 10.1159/000485115. Epub 2017 Nov 20.

3.

Detection of KRAS Exon 2 Mutations in Circulating Tumor Cells Isolated by the ISET System from Patients with RAS Wild Type Metastatic Colorectal Cancer.

Matikas A, Voutsina A, Lagoudaki E, Hatzidaki D, Trypaki M, Stoupis G, Tzardi M, Mavroudis D, Georgoulias V.

Transl Oncol. 2017 Aug;10(4):693-698. doi: 10.1016/j.tranon.2017.06.005. Epub 2017 Jul 7.

Supplemental Content

Loading ...
Support Center